Welcome
Support Centre
10 February 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
Which intravenous fluid should be given for hospitalized patients?: A prospective randomised study
ISRCTN ISRCTN75155444
ClinicalTrials.gov identifier
Public title Which intravenous fluid should be given for hospitalized patients?: A prospective randomised study
Scientific title
Acronym N/A
Serial number at source N/A
Study hypothesis The hypothesize of the study is that in sick children, moderately hypotonic fluids (such as fluids contain 77 mmol/L sodium) are better tolerated (i.e. induce less hyponatraemia without the risk of hypernatraemia) than conventional intravenous fluids that contain 34 mmol/L sodium.
Lay summary
Ethics approval Ethical Board of Istanbul University, Istanbul Faculty of Medicine, approved on 13 June 2005. Ref: 2005/526.
Study design Randomized controlled trial.
Countries of recruitment Turkey
Disease/condition/study domain Hyponatraemia
Participants - inclusion criteria All children aged between 3 months to 16 years old who received intravenous fluids
Participants - exclusion criteria 1. Dehydration
2. Cerebral oedema
3. Nephrotic syndrome
4. Hepatorenal syndrome
5. Plasma sodium level below 135 mmol/L
6. Congestive heart failure
7. Renal failure
8. Inborn error of metabolism
9. Protein energy malnutrition
10. Patients receiving mannitol or diuretics
11. Patients whose fluid therapy was started before admission
Anticipated start date 15/06/2005
Anticipated end date 26/05/2006
Status of trial Completed
Patient information material
Target number of participants 100
Interventions The patients were randomized to one of the three study arms prospectively. Stratified block randomization was performed, with each one-week block featuring a different intravenous solution. Randomization was performed separately for children on the ward and children in the Paediatric Intensive Care Unit (PICU).

Arm 1: 0.2% sodium in 5% dextrose
Arm 2: 0.3% sodium in 3.3% dextrose
Arm 3: 0.45% sodium in 5% dextrose

When hyponatraemia developed in any group during the therapy intravenous fluid sodium composition was increased and fluid therapy was decreased to 80% of the initial volume.
Primary outcome measure(s) Association between administration of hypotonic fluids and hospital-acquired hyponatraemia, assessed by the following:
1. Plasma sodium, potassium and osmolality in all blood samples collected at admission (T0) and 12 (T12), 24 (T24), 48 (T48) and 72 (T72) hours of intravenous fluids therapy
2. Plasma urea, creatinine and uric acid, measured in all blood samples collected at T0 and T24
Secondary outcome measure(s) To determine contributive factors that may increase hyponatraemia risk, assessed by the following:
1. Plasma sodium, potassium and osmolality in all blood samples collected at admission (T0) and 12 (T12), 24 (T24), 48 (T48) and 72 (T72) hours of intravenous fluids therapy.
2. Plasma urea, creatinine and uric acid, measured in all blood samples collected at T0 and T24.
3. Plasma AntiDiuretic Hormone (ADH), measured at T0. Abnormal ADH function was assessed by serum osmolality and serum sodium determinations.
Sources of funding Mainly investigator-funded with support from Ege Medical Company (Turkey)
Trial website
Publications
Contact name Prof  Metin   Karaböcüoğlu
  Address Istanbul University
Istanbul Faculty of Medicine
Department of Paediatric Intensive Care
Millet Cad
Fındıkzade
  City/town Istanbul
  Zip/Postcode 34390
  Country Turkey
  Tel +01190 5332341818
  Fax +01190 2123698564
  Email mkara63@hotmail.com
Sponsor Istanbul University, Faculty of Medicine (Turkey)
  Address Department of Paediatric Intensive Care
Millet Cad
Fındıkzade
  City/town Istanbul
  Zip/Postcode 34390
  Country Turkey
Date applied 14/05/2007
Last edited 10/03/2008
Date ISRCTN assigned 28/09/2007
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central